ARIPIPRAZOLE IP/BP/USP/EP

✅ ARIPIPRAZOLE (IP/BP/USP/EP) – PRODUCT DESCRIPTION

Aripiprazole (CAS 129722-12-9) is an atypical antipsychotic medication used primarily in the treatment of schizophrenia, bipolar disorder, and major depressive disorder. It works by balancing the levels of certain neurotransmitters in the brain, such as dopamine and serotonin, which are involved in mood regulation. Aripiprazole is known for its partial agonist activity at dopamine D2 receptors, which helps improve symptoms related to psychosis, mania, and depression. This white to off-white crystalline powder is used in the production of oral tablets, oral solution, and injectable formulations. Aripiprazole is supplied in pharmaceutical grades (IP/BP/USP/EP) and meets stringent quality standards for use in clinical treatments. We provide Aripiprazole to pharmaceutical manufacturers, healthcare providers, and research organizations worldwide, ensuring high-quality and reliable supply to USA, Malaysia, Vietnam, and Chile.

📦 Industries Used In:

• Pharmaceuticals (treatment of schizophrenia, bipolar disorder, and depression)

• Healthcare (prescribed for managing mental health conditions and mood disorders)

• Research (studies on dopamine, serotonin, and psychiatric disorders)

• Manufacturing (production of oral and injectable formulations)

🧪 Available Grades:

• Pharmaceutical Grade (IP/BP/USP/EP)

• Reagent Grade

• Laboratory Grade

⚙️ Functions:

• Atypical antipsychotic for the treatment of schizophrenia and bipolar disorder

• Partial agonist at dopamine D2 receptors, helping balance neurotransmitter levels

• Effective treatment for major depressive disorder and mania

• Improves symptoms related to psychosis, depression, and mood swings

• Reagent for psychiatric research and drug development

🧩 Classified Under:

• Pharmaceuticals

• Antipsychotics

• Bipolar Disorder Medications

• Schizophrenia Treatment

• Active Pharmaceutical Ingredients (APIs)

• Psychiatric and Mental Health Medications